BioLife Solutions Inc (BLFS)
Profitability ratios
Return on sales
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | |
|---|---|---|---|---|---|
| Gross profit margin | 25.21% | -17.59% | 52.63% | 48.59% | 10.94% |
| Operating profit margin | -49.66% | -90.40% | -29.59% | -12.98% | -0.80% |
| Pretax margin | -46.46% | -89.96% | -24.43% | -2.66% | -11.69% |
| Net profit margin | -46.57% | -86.84% | -7.50% | 4.12% | -6.05% |
BioLife Solutions Inc's profitability ratios have shown significant fluctuations over the past five years. The gross profit margin has varied widely, from negative values in 2022 to over 50% in 2021. This indicates inconsistency in the company's ability to generate profits after accounting for the cost of goods sold.
The operating profit margin has also been volatile, with negative values consistently recorded over the period. The company has struggled to control its operating expenses relative to its revenue, resulting in substantial operating losses.
Similarly, the pretax margin and net profit margin have exhibited inconsistency and negativity over the years. BioLife Solutions Inc has faced challenges in generating profits before and after tax expenses, with 2022 and 2023 showing particularly steep declines in profitability.
Overall, the company's profitability ratios suggest a lack of stable and sustainable profitability, highlighting the need for improved cost control measures, revenue management, and overall financial performance.
Return on investment
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | |
|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | -17.16% | -32.33% | -6.34% | -2.66% | -0.24% |
| Return on assets (ROA) | -16.10% | -31.05% | -1.61% | 0.84% | -1.79% |
| Return on total capital | -19.90% | -37.51% | -7.26% | -3.04% | -7.37% |
| Return on equity (ROE) | -19.67% | -38.39% | -1.86% | 0.97% | -3.82% |
BioLife Solutions Inc has shown a consistent decline in profitability ratios over the past five years, indicating challenges in generating profits relative to its assets and capital. The Operating Return on Assets (Operating ROA) has fluctuated, with a sharp decline in 2022 and 2023, suggesting inefficiencies in utilizing assets to generate operating income. The Return on Assets (ROA) also reflects a negative trend, indicating a decrease in the company's ability to generate profits from its total assets.
The Return on Total Capital has consistently decreased over the years, indicating a decline in the company's ability to generate profits from both equity and debt capital investments. The Return on Equity (ROE) follows a similar negative trajectory, showing a decreasing trend in the profitability generated for the shareholders' equity.
Overall, the declining profitability ratios suggest challenges in effectively utilizing assets and capital to generate profits, highlighting potential inefficiencies or other underlying issues within BioLife Solutions Inc's operations. Tracking these ratios over time can help stakeholders assess the company's financial performance and make informed decisions about its future prospects.